EBOS to acquire LifeHealthcare
NZX- and ASX-listed EBOS was assisted on its proposed acquisition of LifeHealthcare.
Firm: King & Wood Mallesons (EBOS)
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
Deal: King & Wood Mallesons (KWM) has advised the NZX- and ASX-listed New Zealand company EBOS Group Limited on its proposed acquisition of LifeHealthcare from funds advised by Pacific Equity Partners.
Value: Total consideration of $1.167 billion. KWM also advised on $642 million placement, up to $100 million share purchase plan and $540 million new term debt facilities.
Area: M&A.
Key players: The KWM team was led by partners Lee Horan, David Friedlander, Yuen-Yee Cho and Tim Sherman, special counsel Amanda Isouard, senior associates Genovieve Lajeunesse, Emily Campbell and Victoria Lanyon, and solicitors Yang Yang, Nathan Finch and Vivien Ding.
Deal significance: Commenting on the transaction, Mr Horan said: “We were delighted to have worked with EBOS on this strategically important transaction.
“The KWM team included experts from its private equity, capital markets, debt financing, competition, FIRB, tax and employment teams across its Australian and Asian offices, who worked seamlessly together to produce a great outcome.”